Subscribe
shutterstock_1203587437_ratlos
ratlos / Shutterstock.com
3 September 2019Big PharmaSarah Morgan

No-deal Brexit could ‘irreparably’ harm NHS and delay drugs: BMA

Leaving the EU without a deal in place could “irreparably” harm the UK’s National Health Service (NHS) and lead to delays in new products being bought to market in the country, according to the British Medical Association (BMA).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.
Big Pharma
UK faces medicine shortages after no deal: leaked govt report
21 August 2019   A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024
Unified Patent Court
Does the UPC offer a fresh take on patent validity?
5 September 2024

More on this story

Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.
Big Pharma
UK faces medicine shortages after no deal: leaked govt report
21 August 2019   A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

More on this story

Big Pharma
Pharma bodies sign NDAs with UK govt over no-deal Brexit plans
16 August 2019   Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.
Big Pharma
UK faces medicine shortages after no deal: leaked govt report
21 August 2019   A leaked UK government report reveals that a no deal Brexit may result in shortages of medicines and other pharmaceutical products.

More features

President Trump 2.0: Five major areas to watch
Startup CFO’s betrayal is a lesson in preparing for the worst
Sandoz lands reduced antitrust award of $70m
New president’s to-do list: Patent bills, non-competes, USPTO director?
Sanofi subsidiary fends off $450m trade secrets case
Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?